Nothing Special   »   [go: up one dir, main page]

Iova et al., 2014 - Google Patents

Oxidative stress in Alzheimer's dementia

Iova et al., 2014

View PDF
Document ID
1349570154258705201
Author
Iova A
Micle O
VICAȘ L
Micle L
Iova S
MUREȘAN M
IONIȚĂ C
Publication year
Publication venue
Age

External Links

Snippet

OXIDATIVE STRESS IN ALZHEIMER’S DEMENTIA Page 1 FARMACIA, 2014, Vol. 62, 3 546 OXIDATIVE STRESS IN ALZHEIMER’S DEMENTIA ANDRADA IOVA1, OTILIA MICLE1*, LAURA VICAȘ2, LIANA MICLE1, SORIN IOVA1, MARIANA MUREȘAN1, CORINA ANA IONIȚĂ3 …
Continue reading at farmaciajournal.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds

Similar Documents

Publication Publication Date Title
Alfredsson et al. Insufficient sun exposure has become a real public health problem
Weidling et al. Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis
Lloret et al. The effectiveness of vitamin E treatment in Alzheimer’s disease
Bagheri et al. Role of copper in the onset of Alzheimer’s disease compared to other metals
Masoumi et al. 1α, 25-Dihydroxyvitamin D 3 interacts with curcuminoids to stimulate amyloid-β clearance by macrophages of Alzheimer's disease patients
Reddy et al. Mitochondria-division inhibitor 1 protects against amyloid-β induced mitochondrial fragmentation and synaptic damage in Alzheimer’s disease
Tadokoro et al. Prevention of cognitive decline in Alzheimer’s disease by novel antioxidative supplements
Amemori et al. Alzheimer’s disease: mechanism and approach to cell therapy
García-Revilla et al. Reformulating pro-oxidant microglia in neurodegeneration
Chondrogianni et al. Proteasome activation delays aging in vitro and in vivo
Cao et al. Identification of novel genes that modify phenotypes induced by Alzheimer's β-amyloid overexpression in Drosophila
Ho et al. Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease
DuBoff et al. Why size matters–balancing mitochondrial dynamics in Alzheimer's disease
Kuruva et al. Aqua-soluble DDQ reduces the levels of Drp1 and A β and inhibits abnormal interactions between A β and Drp1 and protects Alzheimer’s disease neurons from A β-and Drp1-induced mitochondrial and synaptic toxicities
Francesconi et al. Increased annexin-V and decreased TNF-alpha serum levels in chronic-medicated patients with schizophrenia
Wai et al. Phenotypic and functional changes in glial cells as a function of age
Hock et al. Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid β‐peptide in patients with Alzheimer's disease
Pacheco et al. Association between Machado–Joseph disease and oxidative stress biomarkers
Olivera-Perez et al. Omega-3 fatty acids increase the unfolded protein response and improve amyloid-β phagocytosis by macrophages of patients with mild cognitive impairment
Rai et al. Sestrin2 as serum protein marker and potential therapeutic target for Parkinson’s disease
Princiotta Cariddi et al. Alzheimer’s disease: from immune homeostasis to neuroinflammatory condition
Aganzo et al. Customized dietary intervention avoids unintentional weight loss and modulates circulating miRNAs footprint in huntington's disease
Ibanez et al. Advances in genetic and molecular understanding of Alzheimer’s disease
Iova et al. Oxidative stress in Alzheimer’s dementia
Bermejo-Bescós et al. A diet containing rutin ameliorates brain intracellular redox homeostasis in a mouse model of Alzheimer’s disease